<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7F06A235-D83F-4EDF-A8A3-9216E21C9752"><gtr:id>7F06A235-D83F-4EDF-A8A3-9216E21C9752</gtr:id><gtr:name>Charles University</gtr:name><gtr:address><gtr:line1>Ke Karlovu 3</gtr:line1><gtr:postCode>121 16 Pra</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Czech Republic</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/94480D9F-13DC-42B8-8D53-95577C536E20"><gtr:id>94480D9F-13DC-42B8-8D53-95577C536E20</gtr:id><gtr:name>Icelandic Heart Association (IHA)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7F06A235-D83F-4EDF-A8A3-9216E21C9752"><gtr:id>7F06A235-D83F-4EDF-A8A3-9216E21C9752</gtr:id><gtr:name>Charles University</gtr:name><gtr:address><gtr:line1>Ke Karlovu 3</gtr:line1><gtr:postCode>121 16 Pra</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Czech Republic</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/94480D9F-13DC-42B8-8D53-95577C536E20"><gtr:id>94480D9F-13DC-42B8-8D53-95577C536E20</gtr:id><gtr:name>Icelandic Heart Association (IHA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B41793F2-99CD-473E-9648-37BB28391EAB"><gtr:id>B41793F2-99CD-473E-9648-37BB28391EAB</gtr:id><gtr:firstName>Nigel</gtr:firstName><gtr:surname>Loveridge</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A6368FE4-1956-455B-9FFB-5BB505FEC52F"><gtr:id>A6368FE4-1956-455B-9FFB-5BB505FEC52F</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Bearcroft</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C1337FF8-654C-479E-8192-BA294CE68C37"><gtr:id>C1337FF8-654C-479E-8192-BA294CE68C37</gtr:id><gtr:firstName>Ken</gtr:firstName><gtr:surname>Poole</gtr:surname><gtr:orcidId>0000-0003-4546-7352</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/013DC3EF-B31F-42E6-B402-47A9A0BFAC0D"><gtr:id>013DC3EF-B31F-42E6-B402-47A9A0BFAC0D</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Reeve</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501550"><gtr:id>7A4AE978-6F8B-47B4-B758-B40A2F9892D7</gtr:id><gtr:title>Cortical thinning measured in vivo: key determinant of hip fracture risk</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501550</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>67276</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Charles University</gtr:collaboratingOrganisation><gtr:country>Czech Republic</gtr:country><gtr:department>School of Medicine Charles Prague</gtr:department><gtr:description>Effect of Cortical Thinning on Hip Fracture Risk</gtr:description><gtr:id>932FEF61-AE08-4E10-93CA-5328DAEC9BB7</gtr:id><gtr:impact>PMID:21473947 from the Icelandic group's work. The Czech study has only been published in abstract form so far.
Disciplines: Medicine, Orthopaedics, Radiology, Structural Engineering</gtr:impact><gtr:outcomeId>pVkm3RLZBXh-2</gtr:outcomeId><gtr:partnerContribution>Evaluated their results for hip fracture as an outcome in the Prospective AGES study, which collected computed tomography data on the hip on recruitment. Tested our hypothesis that cortical thinning is a strong determinant of hip fracture risk, with positive results.They have provided data from a Case-Control study of the structure of the femoral neck in hip fracture, to provide a re-test of the results obtained by outr Icelandic collaborators.</gtr:partnerContribution><gtr:piContribution>Trained lead author in Computed Tomography data evaluation and contributed to design of study. Contributed to analysis and assessment of results and to writing the resulting scientific paper.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Icelandic Heart Association (IHA)</gtr:collaboratingOrganisation><gtr:country>Iceland, Republic of</gtr:country><gtr:department>AGES Study</gtr:department><gtr:description>Effect of Cortical Thinning on Hip Fracture Risk</gtr:description><gtr:id>FE473312-F6F7-4B8F-AA18-E702EB2F3B46</gtr:id><gtr:impact>PMID:21473947 from the Icelandic group's work. The Czech study has only been published in abstract form so far.
Disciplines: Medicine, Orthopaedics, Radiology, Structural Engineering</gtr:impact><gtr:outcomeId>pVkm3RLZBXh-1</gtr:outcomeId><gtr:partnerContribution>Evaluated their results for hip fracture as an outcome in the Prospective AGES study, which collected computed tomography data on the hip on recruitment. Tested our hypothesis that cortical thinning is a strong determinant of hip fracture risk, with positive results.They have provided data from a Case-Control study of the structure of the femoral neck in hip fracture, to provide a re-test of the results obtained by outr Icelandic collaborators.</gtr:partnerContribution><gtr:piContribution>Trained lead author in Computed Tomography data evaluation and contributed to design of study. Contributed to analysis and assessment of results and to writing the resulting scientific paper.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>National Osteoporosis Society Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>353A69B0-CEFD-4F68-8878-8E2D205327E3</gtr:id><gtr:impact>Talk

They seemed to like the talk</gtr:impact><gtr:outcomeId>19B2D4B3A13</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Cambridge Biomedical Research Centre</gtr:department><gtr:description>Centre Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>77841DBA-15AE-4756-85DA-00A912C43D5D</gtr:id><gtr:outcomeId>KXP4k2mqLVx0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Fellowship for KE Poole</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>B181A42A-BA5B-4C12-9CE8-E1B11D89A687</gtr:id><gtr:outcomeId>MPkW31mX79H0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Upgrade to Mindways software for bone analysis (hip)</gtr:description><gtr:grantRef>G0501550</gtr:grantRef><gtr:id>48E03493-4755-4F22-8965-F87FE2508DDC</gtr:id><gtr:impact>A ms is in preparation from the AGES (Iceland ) study testing the ideas on hip fragility that we developed and using the same method of analysis. It is a nested case control study embedded in this well-known cohort study which is also collaborating with us on the genetics of osteoporotic fracture (GEFOS, funded by the EU FP7). Basically the results are supportive of our hypotheses and were presented at the American Soc for Bone &amp;amp; Mineral Research in Sept.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>FA18C8045AE</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>Software (Mindways)</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>100 women who turned out to be healthy aged 20-85</gtr:description><gtr:id>D00F1A2F-C1D4-48E3-8500-54D96DE57FC3</gtr:id><gtr:impact>The method is being used by other groups, eg Rejkyavik AGES group</gtr:impact><gtr:outcomeId>ECC91D8F9E0</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>reference data-base and new method for data analysis</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E750EB26-EE24-44DF-8913-A7CB3F227884</gtr:id><gtr:title>The fragile elderly hip: mechanisms associated with age-related loss of strength and toughness.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8173dd304d4e3f8644b50666371881e0"><gtr:id>8173dd304d4e3f8644b50666371881e0</gtr:id><gtr:otherNames>Reeve J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_540e146e1464f2275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>691605E3-EF4D-4631-8259-000533D4B367</gtr:id><gtr:title>Distribution of cortical bone in the femoral neck and hip fracture: a prospective case-control analysis of 143 incident hip fractures; the AGES-REYKJAVIK Study.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff150af71d466d1e3a3012fb79d33c9"><gtr:id>bff150af71d466d1e3a3012fb79d33c9</gtr:id><gtr:otherNames>Johannesdottir F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn><gtr:outcomeId>pm_14248_28_21473947</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>446D7169-5757-40D6-836B-9AAE78619394</gtr:id><gtr:title>Femoral neck trabecular bone: loss with aging and role in preventing fracture.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f629fe95b1cd4822c06bfe22898dd92"><gtr:id>5f629fe95b1cd4822c06bfe22898dd92</gtr:id><gtr:otherNames>Thomas CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>UuWjSgpWZjf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>424DF53D-E4FB-4E35-AD38-78880E6064F4</gtr:id><gtr:title>Changing structure of the femoral neck across the adult female lifespan.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85848b7e23ec451196103d75efdac15a"><gtr:id>85848b7e23ec451196103d75efdac15a</gtr:id><gtr:otherNames>Poole KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>pm_14248_18_19594320</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501550</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>